Detalles de la búsqueda
1.
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Oncologist;
2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38873934
2.
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Oncologist;
2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38815151
3.
Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.
Cancer;
130(13): 2361-2371, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38396300
4.
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.
Cancer;
130(6): 947-961, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37933882
5.
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma.
EJHaem;
4(4): 921-926, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38024612
6.
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
J Natl Cancer Inst;
115(11): 1355-1363, 2023 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37228094
7.
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
J Clin Oncol;
41(11): 2098-2107, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669140
8.
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
Cancer;
128(21): 3775-3783, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36101004
9.
Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network.
Cancer;
128(21): 3843-3849, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089859
10.
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.
J Clin Oncol;
40(20): 2235-2245, 2022 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35363510
11.
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
J Clin Oncol;
40(20): 2224-2234, 2022 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353553
12.
More Questions Than Answers for Adolescents and Young Adults With Cancer.
JNCI Cancer Spectr;
5(3)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250442
13.
Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016.
Cancer;
127(22): 4277-4286, 2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34308557
14.
ARID5B Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia.
Clin Cancer Res;
26(1): 256-264, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31573954
15.
Precision Medicine in Pediatric Oncology.
Surg Oncol Clin N Am;
29(1): 63-72, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31757314
16.
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.
J Clin Oncol;
37(30): 2769-2777, 2019 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31449468
17.
National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
Cancer J;
25(4): 272-281, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31335391
18.
Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: a report from the Children's Oncology Group.
Leukemia;
33(9): 2144-2154, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30816331
19.
Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).
Pediatr Blood Cancer;
66(1): e27450, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30255545
20.
Reply to D.M. Green.
J Clin Oncol;
: JCO1800659, 2018 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30212299